ym 16638 has been researched along with Muscle Contraction in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kamato, T; Miyata, K; Nishida, A; Takeda, M; Takizawa, K | 1 |
| Hara, H; Mase, T; Murase, K; Tomioka, K; Yamada, T | 1 |
2 other study(ies) available for ym 16638 and Muscle Contraction
| Article | Year |
|---|---|
Gastric mucosal protection by YM638, a novel leukotriene D4 receptor antagonist, in rats.
Topics: Animals; Capillary Permeability; Ethanol; Gastric Acid; Gastric Mucosa; In Vitro Techniques; Leukotriene Antagonists; Male; Membrane Proteins; Muscle Contraction; Rats; Rats, Wistar; Receptors, Leukotriene; Thiadiazoles | 1995 |
Pharmacological properties of the orally active leukotriene antagonist [[5-[[3-(4-acetyl-3-hydroxy-2-propylphenoxy)-propyl]thio]-1,3,4- thiadiazol-2-yl]thio]acetic acid.
Topics: Animals; Asthma; Guinea Pigs; Humans; Ileum; In Vitro Techniques; Lung; Muscle Contraction; Muscle, Smooth; Skin Tests; SRS-A; Thiadiazoles; Trachea | 1988 |